DLH HOLDINGS CORP (DLHC) Fundamental Analysis & Valuation

NASDAQ:DLHC • US23335Q1004

5.85 USD
0 (0%)
Last: Mar 6, 2026, 08:12 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This DLHC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

DLHC gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 88 industry peers in the Professional Services industry. DLHC may be in some trouble as it scores bad on both profitability and health. DLHC does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. DLHC Profitability Analysis

1.1 Basic Checks

  • DLHC had negative earnings in the past year.
  • DLHC had a positive operating cash flow in the past year.
  • In the past 5 years DLHC has always been profitable.
  • In the past 5 years DLHC always reported a positive cash flow from operatings.
DLHC Yearly Net Income VS EBIT VS OCF VS FCFDLHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

1.2 Ratios

  • DLHC has a Return On Assets of -0.38%. This is comparable to the rest of the industry: DLHC outperforms 42.05% of its industry peers.
  • With a Return On Equity value of -0.96%, DLHC perfoms like the industry average, outperforming 42.05% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 4.49%, DLHC is in line with its industry, outperforming 46.59% of the companies in the same industry.
  • DLHC had an Average Return On Invested Capital over the past 3 years of 7.48%. This is significantly below the industry average of 12.74%.
Industry RankSector Rank
ROA -0.38%
ROE -0.96%
ROIC 4.49%
ROA(3y)1.08%
ROA(5y)4.44%
ROE(3y)3.12%
ROE(5y)10.02%
ROIC(3y)7.48%
ROIC(5y)11.41%
DLHC Yearly ROA, ROE, ROICDLHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • DLHC's Profit Margin has declined in the last couple of years.
  • DLHC has a Operating Margin of 3.90%. This is comparable to the rest of the industry: DLHC outperforms 47.73% of its industry peers.
  • In the last couple of years the Operating Margin of DLHC has declined.
  • DLHC's Gross Margin of 18.68% is on the low side compared to the rest of the industry. DLHC is outperformed by 73.86% of its industry peers.
  • In the last couple of years the Gross Margin of DLHC has declined.
Industry RankSector Rank
OM 3.9%
PM (TTM) N/A
GM 18.68%
OM growth 3Y-17.18%
OM growth 5Y-6.68%
PM growth 3Y-59.37%
PM growth 5Y-34.95%
GM growth 3Y1.12%
GM growth 5Y-2.8%
DLHC Yearly Profit, Operating, Gross MarginsDLHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. DLHC Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so DLHC is destroying value.
  • The number of shares outstanding for DLHC has been increased compared to 1 year ago.
  • The number of shares outstanding for DLHC has been increased compared to 5 years ago.
  • DLHC has a better debt/assets ratio than last year.
DLHC Yearly Shares OutstandingDLHC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M
DLHC Yearly Total Debt VS Total AssetsDLHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • Based on the Altman-Z score of 1.62, we must say that DLHC is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of DLHC (1.62) is worse than 61.36% of its industry peers.
  • The Debt to FCF ratio of DLHC is 4.41, which is a neutral value as it means it would take DLHC, 4.41 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of DLHC (4.41) is comparable to the rest of the industry.
  • DLHC has a Debt/Equity ratio of 1.03. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 1.03, DLHC is doing worse than 71.59% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 4.41
Altman-Z 1.62
ROIC/WACC0.44
WACC10.19%
DLHC Yearly LT Debt VS Equity VS FCFDLHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.3 Liquidity

  • DLHC has a Current Ratio of 0.97. This is a bad value and indicates that DLHC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • DLHC's Current ratio of 0.97 is on the low side compared to the rest of the industry. DLHC is outperformed by 78.41% of its industry peers.
  • DLHC has a Quick Ratio of 0.97. This is a bad value and indicates that DLHC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • DLHC has a worse Quick ratio (0.97) than 78.41% of its industry peers.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.97
DLHC Yearly Current Assets VS Current LiabilitesDLHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. DLHC Growth Analysis

3.1 Past

  • DLHC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -104.55%.
  • The earnings per share for DLHC have been decreasing by -29.88% on average. This is quite bad
  • DLHC shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -17.04%.
  • Measured over the past years, DLHC shows a quite strong growth in Revenue. The Revenue has been growing by 10.49% on average per year.
EPS 1Y (TTM)-104.55%
EPS 3Y-57.47%
EPS 5Y-29.88%
EPS Q2Q%-150%
Revenue 1Y (TTM)-17.04%
Revenue growth 3Y-4.47%
Revenue growth 5Y10.49%
Sales Q2Q%-24.11%

3.2 Future

  • Based on estimates for the next years, DLHC will show a very negative growth in Earnings Per Share. The EPS will decrease by -51.86% on average per year.
  • The Revenue is expected to decrease by -14.42% on average over the next years. This is quite bad
EPS Next Y-457%
EPS Next 2Y-51.86%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-32.07%
Revenue Next 2Y-14.42%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DLHC Yearly Revenue VS EstimatesDLHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
DLHC Yearly EPS VS EstimatesDLHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

2

4. DLHC Valuation Analysis

4.1 Price/Earnings Ratio

  • DLHC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DLHC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DLHC Price Earnings VS Forward Price EarningsDLHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200

4.2 Price Multiples

  • DLHC's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. DLHC is cheaper than 81.82% of the companies in the same industry.
  • DLHC's Price/Free Cash Flow ratio is rather cheap when compared to the industry. DLHC is cheaper than 98.86% of the companies in the same industry.
Industry RankSector Rank
P/FCF 2.8
EV/EBITDA 7.33
DLHC Per share dataDLHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • DLHC's earnings are expected to decrease with -51.86% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-51.86%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DLHC Dividend Analysis

5.1 Amount

  • DLHC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DLHC Fundamentals: All Metrics, Ratios and Statistics

DLH HOLDINGS CORP

NASDAQ:DLHC (3/6/2026, 8:12:29 PM)

5.85

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)02-09
Earnings (Next)05-05
Inst Owners66%
Inst Owner Change2.25%
Ins Owners14.1%
Ins Owner Change2.5%
Market Cap84.77M
Revenue(TTM)322.61M
Net Income(TTM)-1.08M
Analysts82.86
Price Target10.2 (74.36%)
Short Float %0.53%
Short Ratio4.84
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-126.05%
Min EPS beat(2)-296.08%
Max EPS beat(2)43.98%
EPS beat(4)1
Avg EPS beat(4)-67.51%
Min EPS beat(4)-296.08%
Max EPS beat(4)43.98%
EPS beat(8)3
Avg EPS beat(8)-33.61%
EPS beat(12)6
Avg EPS beat(12)-22.6%
EPS beat(16)9
Avg EPS beat(16)-9.67%
Revenue beat(2)0
Avg Revenue beat(2)-4.53%
Min Revenue beat(2)-5.28%
Max Revenue beat(2)-3.79%
Revenue beat(4)0
Avg Revenue beat(4)-3.36%
Min Revenue beat(4)-5.28%
Max Revenue beat(4)-1.56%
Revenue beat(8)1
Avg Revenue beat(8)-4.03%
Revenue beat(12)1
Avg Revenue beat(12)-4.06%
Revenue beat(16)2
Avg Revenue beat(16)-3.11%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-100%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-29.63%
Revenue NQ rev (1m)-10.77%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.84%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.26
P/FCF 2.8
P/OCF 2.83
P/B 0.76
P/tB N/A
EV/EBITDA 7.33
EPS(TTM)-0.02
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)2.09
FCFY35.69%
OCF(TTM)2.07
OCFY35.37%
SpS22.26
BVpS7.74
TBVpS-7.85
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.38%
ROE -0.96%
ROCE 5.19%
ROIC 4.49%
ROICexc 4.5%
ROICexgc 66.78%
OM 3.9%
PM (TTM) N/A
GM 18.68%
FCFM 9.38%
ROA(3y)1.08%
ROA(5y)4.44%
ROE(3y)3.12%
ROE(5y)10.02%
ROIC(3y)7.48%
ROIC(5y)11.41%
ROICexc(3y)7.49%
ROICexc(5y)11.97%
ROICexgc(3y)141.56%
ROICexgc(5y)N/A
ROCE(3y)8.65%
ROCE(5y)13.18%
ROICexgc growth 3Y-13.01%
ROICexgc growth 5Y-1.07%
ROICexc growth 3Y-36.15%
ROICexc growth 5Y-8.79%
OM growth 3Y-17.18%
OM growth 5Y-6.68%
PM growth 3Y-59.37%
PM growth 5Y-34.95%
GM growth 3Y1.12%
GM growth 5Y-2.8%
F-Score4
Asset Turnover1.14
Health
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 4.41
Debt/EBITDA 3.9
Cap/Depr 1.58%
Cap/Sales 0.08%
Interest Coverage 0.97
Cash Conversion 100.76%
Profit Quality N/A
Current Ratio 0.97
Quick Ratio 0.97
Altman-Z 1.62
F-Score4
WACC10.19%
ROIC/WACC0.44
Cap/Depr(3y)3.44%
Cap/Depr(5y)4.59%
Cap/Sales(3y)0.15%
Cap/Sales(5y)0.14%
Profit Quality(3y)1375.61%
Profit Quality(5y)915.51%
High Growth Momentum
Growth
EPS 1Y (TTM)-104.55%
EPS 3Y-57.47%
EPS 5Y-29.88%
EPS Q2Q%-150%
EPS Next Y-457%
EPS Next 2Y-51.86%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-17.04%
Revenue growth 3Y-4.47%
Revenue growth 5Y10.49%
Sales Q2Q%-24.11%
Revenue Next Year-32.07%
Revenue Next 2Y-14.42%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-46.94%
EBIT growth 3Y-20.88%
EBIT growth 5Y3.11%
EBIT Next Year17.09%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y9.16%
FCF growth 3Y295.63%
FCF growth 5Y3.55%
OCF growth 1Y6.59%
OCF growth 3Y165.32%
OCF growth 5Y3.6%

DLH HOLDINGS CORP / DLHC FAQ

What is the fundamental rating for DLHC stock?

ChartMill assigns a fundamental rating of 2 / 10 to DLHC.


What is the valuation status of DLH HOLDINGS CORP (DLHC) stock?

ChartMill assigns a valuation rating of 2 / 10 to DLH HOLDINGS CORP (DLHC). This can be considered as Overvalued.


What is the profitability of DLHC stock?

DLH HOLDINGS CORP (DLHC) has a profitability rating of 3 / 10.


How financially healthy is DLH HOLDINGS CORP?

The financial health rating of DLH HOLDINGS CORP (DLHC) is 1 / 10.